Samir Jana

885 total citations
18 papers, 680 citations indexed

About

Samir Jana is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Samir Jana has authored 18 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Samir Jana's work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (4 papers) and TGF-β signaling in diseases (3 papers). Samir Jana is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (4 papers) and TGF-β signaling in diseases (3 papers). Samir Jana collaborates with scholars based in India, United States and Austria. Samir Jana's co-authors include Arindam Bhattacharyya, Suman Sengupta, Annesha Chatterjee, Ravi Salgia, Sanjay Awasthi, Subir Biswas, Sharad S. Singhal, David Horne, Jyotsana Singhal and Palash Mandal and has published in prestigious journals such as Angewandte Chemie International Edition, Biochemical and Biophysical Research Communications and American Journal Of Pathology.

In The Last Decade

Samir Jana

17 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samir Jana India 13 390 295 219 151 57 18 680
Jelena Anacker Germany 9 343 0.9× 189 0.6× 254 1.2× 105 0.7× 59 1.0× 11 703
Rachel Dalton United States 13 381 1.0× 152 0.5× 294 1.3× 110 0.7× 46 0.8× 20 780
Neil MacLean Canada 17 588 1.5× 253 0.9× 155 0.7× 92 0.6× 34 0.6× 38 816
Csaba László United States 13 395 1.0× 185 0.6× 192 0.9× 82 0.5× 42 0.7× 20 690
Btissame El Hassouni Netherlands 16 371 1.0× 194 0.7× 198 0.9× 59 0.4× 88 1.5× 26 654
Iryna Lebedyeva United States 16 342 0.9× 129 0.4× 115 0.5× 125 0.8× 86 1.5× 35 623
Dawo Liu China 18 456 1.2× 132 0.4× 174 0.8× 187 1.2× 37 0.6× 30 665
Florence Bouyer France 10 250 0.6× 249 0.8× 91 0.4× 130 0.9× 57 1.0× 15 566
Maree Bilandzic Australia 17 391 1.0× 351 1.2× 157 0.7× 154 1.0× 30 0.5× 29 884
Batool Shannan Germany 8 258 0.7× 330 1.1× 79 0.4× 133 0.9× 38 0.7× 11 544

Countries citing papers authored by Samir Jana

Since Specialization
Citations

This map shows the geographic impact of Samir Jana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Jana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Jana more than expected).

Fields of papers citing papers by Samir Jana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Jana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Jana. The network helps show where Samir Jana may publish in the future.

Co-authorship network of co-authors of Samir Jana

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Jana. A scholar is included among the top collaborators of Samir Jana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Jana. Samir Jana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Jana, Samir, et al.. (2021). The Multifaceted Effects of Breast Cancer on Tumor-Draining Lymph Nodes. American Journal Of Pathology. 191(8). 1353–1363. 18 indexed citations
3.
Jana, Samir, Jyotsana Singhal, David Horne, et al.. (2020). SOX9: The master regulator of cell fate in breast cancer. Biochemical Pharmacology. 174. 113789–113789. 52 indexed citations
4.
Jana, Samir, Jyotsana Singhal, David Horne, et al.. (2020). Therapeutic targeting of miRNA-216b in cancer. Cancer Letters. 484. 16–28. 13 indexed citations
6.
Jana, Samir, Aditya K. Panda, David Horné, et al.. (2020). Association of TGF-β1 Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case–Control Studies. Cancers. 12(2). 471–471. 5 indexed citations
7.
Jana, Samir, Jyotsana Singhal, David Horne, et al.. (2019). Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Letters. 461. 123–131. 96 indexed citations
8.
Chatterjee, Annesha, Samir Jana, Soumya Chatterjee, et al.. (2019). MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer. British Journal of Cancer. 121(8). 679–689. 53 indexed citations
9.
Nandy, Arpita, Samir Jana, Moumita Khamrai, et al.. (2019). Cloning and expression of α-amylase inE. coli: genesis of a superior biocatalyst for substrate-specific MFC. International Journal of Green Energy. 16(4). 309–316. 8 indexed citations
10.
11.
Thorne, James L., Sebastiano Battaglia, Josie Hayes, et al.. (2018). MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1861(11). 996–1006. 32 indexed citations
12.
Meier, Samuel M., Dominique Kreutz, Lilli Winter, et al.. (2017). An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin. Angewandte Chemie International Edition. 56(28). 8267–8271. 93 indexed citations
13.
Meier, Samuel M., Dominique Kreutz, Lilli Winter, et al.. (2017). Ein Organoruthenium‐Tumortherapeutikum mit unerwartet hoher Selektivität für Plectin. Angewandte Chemie. 129(28). 8379–8383. 14 indexed citations
14.
Jana, Samir, et al.. (2016). miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP. Biochemical and Biophysical Research Communications. 482(1). 126–133. 46 indexed citations
16.
Biswas, Subir, Suman Sengupta, Sougata Roy Chowdhury, et al.. (2013). CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis. Breast Cancer Research and Treatment. 143(2). 265–276. 116 indexed citations
17.
Sengupta, Suman, Samir Jana, Subir Biswas, Palash Mandal, & Arindam Bhattacharyya. (2013). Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells. Clinical & Experimental Metastasis. 30(8). 1019–1031. 28 indexed citations
18.
Sengupta, Suman, Samir Jana, & Arindam Bhattacharyya. (2013). TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Cellular Signalling. 26(2). 240–252. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026